Globus Medical Inc. has announced a share repurchase program of up to $500 million of its outstanding common stock. The timing and actual number of shares repurchased will be determined by management based on factors such as market conditions and alternative investment opportunities. The company plans to use its cash reserves to fund the repurchase program, which has no set time limit and may be paused or discontinued at any time.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.